SCHEMBL10073808

SCHEMBL10073808

C=CCSC1C(CC2CCCC2)N(S(=O)(=O)c2ccc(C)cc2)C(c2ccc(Cl)cc2)[C@@H]1C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RABGGTB P53611 9/20 0.65
RABGGTA Q92696 9/20 0.65
USP2 O75604 3/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
GFER P55789 2/20 0.37
TAAR1 Q96RJ0 1/20 0.37
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
FKBP1A P62942 1/20 0.35
ACHE P22303 1/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10047271 1.00 RABGGTB (0.65) RABGGTBRABGGTAUSP2CRHBPCRHR2
SCHEMBL10072793 0.92 RABGGTB (0.56) RABGGTBRABGGTAUSP2CRHBPCRHR2
SCHEMBL10047273 0.92 RABGGTB (0.56) RABGGTBRABGGTAUSP2CRHBPCRHR2
SCHEMBL10047251 0.91 RABGGTB (0.59) RABGGTBRABGGTAUSP2CRHBPCRHR2
SCHEMBL10073947 0.91 RABGGTB (0.59) RABGGTBRABGGTAUSP2CRHBPCRHR2
SCHEMBL10047256 0.87 RABGGTB (0.60) RABGGTBRABGGTA
SCHEMBL10072796 0.87 RABGGTB (0.60) RABGGTBRABGGTA
SCHEMBL10047242 0.86 RABGGTB (0.60) RABGGTBRABGGTAUSP2CRHBPCRHR2
SCHEMBL10073966 0.86 RABGGTB (0.60) RABGGTBRABGGTAUSP2CRHBPCRHR2
SCHEMBL14882800 0.86 RABGGTB (0.60) RABGGTBRABGGTAUSP2CRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB RABGGTB 17/4885RABGGTA 5/4885USP2 2188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.